drugset / Trial / NCT00491127

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00491127 ↗

Phase 2 Completed 10 enrolled Eli Lilly and Company
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study it to evaluate efficacy of gemcitabine with cisplatin and dexamethasone in patients with aggressive non-Hodgkin's lymphoma who have previously progressed on first line of chemotherapy with anthracyclines.

Timeline

Start
2003-04
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Dexamethasone Small molecule — —
Subject Gemcitabine Small molecule — —

Indications